PubRank

M G Dunlop

Author PubWeight™ 80.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990 11.24
2 Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1995 3.07
3 TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut 2011 2.75
4 Guidelines for selective radiological assessment of inversion ankle injuries. Br Med J (Clin Res Ed) 1986 2.27
5 APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A 1996 2.18
6 Accuracy of reporting of family history of colorectal cancer. Gut 2004 1.92
7 Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer. Oncogene 1996 1.89
8 High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. Oncogene 1989 1.52
9 Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas. Proc Natl Acad Sci U S A 2002 1.51
10 Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. Am J Epidemiol 2002 1.49
11 MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. Oncogene 1991 1.49
12 Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 1996 1.49
13 Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome. Cancer Res 1997 1.47
14 APC expression in normal human tissues. J Pathol 1997 1.44
15 Association studies on 11 published colorectal cancer risk loci. Br J Cancer 2010 1.31
16 Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am J Hum Genet 1998 1.30
17 Evidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosis. Br J Cancer 2004 1.24
18 Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J 2001 1.17
19 Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Oncogene 1993 1.15
20 Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis. Am J Gastroenterol 2009 1.15
21 A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer 2010 1.11
22 Intravenous drug abuse and the accident and emergency department. Arch Emerg Med 1985 1.06
23 The TERT variant rs2736100 is associated with colorectal cancer risk. Br J Cancer 2012 1.05
24 Bacterial contamination of mobile communication devices in the operative environment. J Hosp Infect 2007 1.02
25 Outcomes of the rectal remnant following colectomy for ulcerative colitis. Colorectal Dis 2007 0.99
26 Molecular genetic basis of colorectal cancer susceptibility. Br J Surg 1996 0.98
27 The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-kappaB. Oncogene 2007 0.98
28 Suggested screening guidelines for familial colorectal cancer. J Med Screen 1995 0.98
29 Assessment of outcomes after colorectal cancer resection in the elderly as a rationale for screening and early detection. Br J Surg 2004 0.97
30 Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomes. Oncogene 2001 0.96
31 Common genetic variants at the MC4R locus are associated with obesity, but not with dietary energy intake or colorectal cancer in the Scottish population. Int J Obes (Lond) 2008 0.96
32 Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent? Fam Cancer 2004 0.96
33 Colonoscopy surveillance of individuals at risk of familial colorectal cancer. Gut 2003 0.96
34 APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis. Br J Cancer 1994 0.95
35 A prospective controlled study of the association of Streptococcus bovis with colorectal carcinoma. J Clin Pathol 1998 0.94
36 Germline mutation prevalence in the base excision repair gene, MYH, in patients with endometrial cancer. Clin Genet 2007 0.91
37 Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min/+) and Apc(Min/+), Msh2(-/-) mice. Cancer Res 2001 0.91
38 Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma. Br J Cancer 2001 0.91
39 Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency. Br J Cancer 2005 0.91
40 Gene therapy for colon cancer. Hematol Oncol Clin North Am 1998 0.90
41 Prevalence of family history of colorectal cancer in the general population. Br J Surg 2005 0.88
42 Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumour suppressor loci involved in colorectal cancer. Oncogene 1996 0.86
43 A prevalence screen of MRSA nasal colonisation amongst UK doctors in a non-clinical environment. Eur J Clin Microbiol Infect Dis 2009 0.86
44 Hypermutability at a poly(A/T) tract in the human germline. Nucleic Acids Res 2001 0.85
45 Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe. Inflamm Bowel Dis 2007 0.84
46 Mutation frequency in coding and non-coding repeat sequences in mismatch repair deficient cells derived from normal human tissue. Oncogene 2001 0.84
47 The MSH2 c.388_389del mutation shows a founder effect in Portuguese Lynch syndrome families. Clin Genet 2012 0.83
48 NF-kappaB kinetics predetermine TNF-alpha sensitivity of colorectal cancer cells. J Gene Med 2001 0.83
49 Sequence interruptions confer differential stability at microsatellite alleles in mismatch repair-deficient cells. Hum Mol Genet 2000 0.82
50 Long-term cancer risk of the anorectal cuff following restorative proctocolectomy assessed by p53 expression and cuff dysplasia. Colorectal Dis 2007 0.82
51 Mosaicism and sporadic familial adenomatous polyposis. Am J Hum Genet 1999 0.81
52 Bacterial contamination of hospital bed-control handsets in a surgical setting: a potential marker of contamination of the healthcare environment. Ann R Coll Surg Engl 2007 0.79
53 The contribution of DNA mismatch repair gene defects to the burden of gynecological cancer. Int J Gynecol Cancer 2003 0.79
54 Distal arterial emboli following seat belt injury of the aorta. Injury 1986 0.79
55 Cranial desmoid tumor associated with homozygous inactivation of the adenomatous polyposis coli gene in a 2-year-old girl with familial adenomatous polyposis. Cancer 1996 0.78
56 Deletion analysis of chromosome 8p in sporadic colorectal adenomas. Br J Cancer 1994 0.78
57 Genetics of colorectal cancer. Br Med Bull 1994 0.78
58 SNP mistyping in genotyping arrays--an important cause of spurious association in case-control studies. Genet Epidemiol 2011 0.78
59 Diverticular disease in Scotland: 2000-2010. Colorectal Dis 2015 0.77
60 Exclusion of constitutional p53 mutations as a cause of genetic susceptibility to colorectal cancer. Br J Cancer 1993 0.77
61 Vascular access: experience with the brachiocephalic fistula. Ann R Coll Surg Engl 1986 0.77
62 Intravenous drug abuse and the accident and emergency department: AIDS (HTLV-III) antibodies and hepatitis B markers. Arch Emerg Med 1986 0.75
63 Presymptomatic diagnosis of polyposis coli by DNA. Gastroenterology 1992 0.75
64 Vacuum drainage of groin wounds after vascular surgery. Br J Surg 1991 0.75
65 Molecular markers of prognosis in colorectal cancer. J Natl Cancer Inst 1999 0.75
66 Infection controls: the hospital bed-control handset. J Hosp Infect 2008 0.75
67 Acute abdominal pain: the value of liver function tests in suspected cholelithiasis. J R Coll Surg Edinb 1989 0.75
68 Heparin-induced platelet factor 4 release in patients with atherosclerotic peripheral vascular disease. Thromb Res 1987 0.75
69 Ankle sprain: an analysis of hospital referral from family practice. Fam Pract 1987 0.75
70 Cascade genetic testing for mismatch repair gene mutations. Fam Cancer 2008 0.75